FDA recall D-0634-2022

Product

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

Reason for recall

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Distribution

CO, OH, and TX.

Key facts

Status

Terminated

Initiation date

2022-02-03

Report date

2022-02-23

Termination date

2022-09-16

Voluntary/Mandated

Voluntary: Firm initiated

Location

Denver, CO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0634-2022